NCT02876757View on ClinicalTrials.gov

5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression

CompletedOBSERVATIONAL
Enrollment

186,394

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2013

Study Completion Date

March 31, 2017

Conditions
BPHDepressionSuicide
Interventions
DRUG

5ARI

Exposure to finasteride/dutasteride

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT02876757 - 5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression | Biotech Hunter | Biotech Hunter